Biotech: internal spending on R&D activities Spain| ��ƽ��

Internal expenditure on research and development activities in biotechnology in Spain from 2009 to 2022 (in million euros)

Characteristic	Expenditure in million euros
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Release date

January 2024

More information

Region

Spain

Survey time period

2009 to 2022

Supplementary notes

The source does not provide a publication date. The release date corresponds to the date of access.

Figures have been rounded.

Citation formats

In 2022, internal expenditure on research and development activities in biotechnology amounted to more than * euros in Spain, the highest value reported since 2009. During the period analyzed, local investment in R&D activities related to the biotech field increased by ** percent. As of 2022, the production value of the biotechnology industry represented approximately *** percent of the Spanish GDP.

The biotechnology sector in Spain

The Spanish biotechnology industry has been expanding in recent years, with a production value of approximately euros in 2022, reflecting a *** percent increase in turnover since 2010, when this figure amounted to just over * euros. Alongside this trend, the number of employees working in internal R&D activities in biotechnology has also increased, with around * workers employed in the sector as of 2022.

Private capital increase

Spanish biotechnology firms raised approximately * euros in private capital increases in 2023, marking the highest private capital increase since 2016, when it stood at euros. Among the companies that received private capital funding, Universal Diagnostics stood out, raising euros in 2023. The biotechnology company specializes in biomarker discovery for the identification of early stage cancer and ranked first among other biotech firms in terms of funding received.